Hr-positive Advanced Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-01
Clinical Trial Update: A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation
A prospective non-interventional study to evaluate clinical outcomes of ribociclib combined with endocrine therapy in elderly patients with …
CLINICAL_TRIALS trial_result · 2023-04-06
Clinical Trial Update: Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating iribrine plus tucidinostat in HR+/HER2- advanced breast cancer after CDK4/6 inhibitor failure is liste…